imatinib mesylate

Type: Keyphrase
Name: imatinib mesylate
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

The Downfall of Pharmaceutical Innovation

REUTERS.COMIndia, the emerging pharmaceutical powerhouse of the developing world, has recently become a battleground between generic and private pharmaceutical companies as they pit public health interests against intellectual property rights. As demand ... [Published Georgetown University Hoya - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

PIRAMAL ENTERPRISES : Patent Issued for Synergistic Pharmaceutical Combination for the Treatment of Cancer

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Rathos, Maggie ( Mumbai , IN); Joshi, Kalpana ( Mumbai , IN); Khanwalkar, Harshal ( Mumbai , IN); ... [Published 4 Traders - Sep 10 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 4 reports

Sun Pharma settles litigation for generic Gleevec in US

Sun Pharmaceutical Industries today announced that one of its subsidiaries has executed a settlement agreement with Novartis Pharmaceuticals Corporation stipulating a dismissal of the lawsuits filed in the United States against the Company regarding submission ... [Published MyIris - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 09 2014 - 1 reports

Court Report - September 2014

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .UCB Inc. et al. v. Watson Laboratories Inc. (NV) et al.1:14-cv-01083; filed August 21, 2014 in the District Court of Delaware• Plaintiffs:  UCB Inc.; UCB ... [Published JD Supra - Sep 08 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Endomyocardial fibrosis in hypereosinophilic syndrome Theodore M Murphy, Deirdre F Waterhouse, Stephanie James, Niamh Murphy, Rory O’Hanlon

Endomyocardial fibrosis in hypereosinophilic syndrome September 2014 Br J Cardiol 2014;21:120 doi: 10.5837/bjc.2014.030 Authors:Theodore M Murphy, Deirdre F Waterhouse, Stephanie James, Niamh Murphy, Rory O’HanlonAn unusual case of endomyocardial fibrosis ... [Published British Journal of Cardiology - Sep 02 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Patent Application Titled "Methods of Treating Multiple Myeloma and Resistant Cancers" Published Online

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a patent application by the inventors Robbins, Paul B. ( Park City, UT ); Sahasrabudhe, Sudhir R. ( Sandy, UT ... [Published 4 Traders - Aug 28 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Personalized Medicine Will Be 'One Size Fits Most' (Op-Ed)

By Mark Lawler, Queen's University BelfastDate: 27 August 2014 Time: 08:31 PM ETTreated as an individual.CREDIT: WhatmatdoesThis article was originally published at The Conversation. The publication contributed the article to Live Science's Expert Voices: ... [Published LiveScience.com - Aug 28 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

How science is using the genetics of disease to make drugs better

Treated as an individual. WhatmatdoesPersonalised medicine is the ability to tailor therapy to an individual patient so that, as it’s often put, the right treatment is given to the right patient at the right time. But just how personal is it?While the ... [Published Conversation UK - Aug 21 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Methods and compositions for modulation of blood-neural barrier

Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy across the BNB. The present invention further relates to improved tPA treatment of ischemic ... [Published PharmCast - Jul 17 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

[Comment] A modest but meaningful decision for Indian drug patents

On April 1, 2013, the Indian Supreme Court released its long-awaited decision on Novartis AG v Union of India & Others, better known as the Glivec (Gleevec in the USA; imatinib mesylate) patent case. Although neither the resounding victory for access ... [Published The Lancet online - Jun 27 2014]
First reported Jun 02 2014 - Updated Jun 02 2014 - 1 reports

GLEEVEC (Imatinib Mesylate) Tablet [Novartis Pharmaceuticals Corporation]

First reported May 19 2014 - Updated May 19 2014 - 1 reports

Novartis agrees Gleevec patent deal

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary to launch a generic version of blockbuster blood cancer drug Gleevec next year.The basic compound patent for Gleevec ... [Published BioPortfolio - May 19 2014]
Entities: Gleevec, Novartis AG, Patent

Quotes

"Other aspects and further scope of applicability of the present invention will become apparent from the detailed description to follow."
Infringement of U S Patent Nos. 6,197,341 ("Formulations of Balsalazide and Its Derivatives," issued March 6, 2001) and 8,497,256 ( "Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males" issued July 30, 2013) following a Paragraph IV certification as part of Mylan's filing of an ANDA to manufacture a generic version of Salix's Giazo®...
"FIG. 4 shows the effect of pulses of Compound 5 of Group I on OPM-2 multiple myeloma cells."

More Content

All (20) | News (17) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
The Downfall of Pharmaceutical Innovation [Published Georgetown University Hoya - Sep 15 2014]
PIRAMAL ENTERPRISES : Patent Issued for Synergi... [Published 4 Traders - Sep 10 2014]
Sun Pharma settles litigation for generic Gleev... [Published MyIris - Sep 09 2014]
Sun Pharma climbs after settlement of lawsuit w... [Published MyIris - Sep 09 2014]
Novartis Drags DRL to US Court Over Patent Infr... [Published New Indian Express - Sep 09 2014]
Novartis drags DRL to US court for patent viola... [Published Financial Express - Sep 08 2014]
Court Report - September 2014 [Published JD Supra - Sep 08 2014]
Endomyocardial fibrosis in hypereosinophilic sy... [Published British Journal of Cardiology - Sep 02 2014]
Patent Application Titled "Methods of Treating ... [Published 4 Traders - Aug 28 2014]
Personalized Medicine Will Be 'One Size Fits Mo... [Published LiveScience.com - Aug 28 2014]
How science is using the genetics of disease to... [Published Conversation UK - Aug 21 2014]
Methods and compositions for modulation of bloo... [Published PharmCast - Jul 17 2014]
[Comment] A modest but meaningful decision for ... [Published The Lancet online - Jun 27 2014]
GLEEVEC (Imatinib Mesylate) Tablet [Novartis Ph... [Published DailyMed Drug Label Updates for the last seven ... - Jun 02 2014]
Novartis agrees Gleevec patent deal [Published BioPortfolio - May 19 2014]
Sun, Novartis settle dispute [Published Calcutta Telegraph - May 15 2014]
Antibody-based arrays for detecting multiple si... [Published PharmCast - Mar 12 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
BSE Healthcare index gains 22.6% during 2013, i... [Published PharmaBiz - Jan 03 2014]
Fact Sheet for SMS Pharmaceuticals Limited [Published Able2Act - May 06 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Comment] A modest but meaningful decision for ... [Published The Lancet online - Jun 27 2014]
On April 1, 2013, the Indian Supreme Court released its long-awaited decision on Novartis AG v Union of India & Others, better known as the Glivec (Gleevec in the USA; imatinib mesylate) patent case. Although neither the resounding victory for access ...
GLEEVEC (Imatinib Mesylate) Tablet [Novartis Ph... [Published DailyMed Drug Label Updates for the last seven ... - Jun 02 2014]
Updated Date: May 29, 2014 EST ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.